$588 Million is the total value of BVF INC/IL's 30 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FWP | FORWARD PHARMA A/Ssponsored adr | $29,908,000 | +43.6% | 1,387,853 | 0.0% | 5.09% | +21.6% | |
| OMED | ONCOMED PHARMACEUTICALS INC | $16,214,000 | +19.5% | 1,760,489 | 0.0% | 2.76% | +1.1% | |
| GLYC | GLYCOMIMETICS INC | $15,347,000 | -11.0% | 2,826,282 | 0.0% | 2.61% | -24.7% | |
| CASC | CASCADIAN THERAPEUTICS INC | $12,972,000 | -3.9% | 3,133,224 | 0.0% | 2.21% | -18.7% | |
| ARQL | ARQULE INC | $7,844,000 | -15.9% | 7,400,128 | 0.0% | 1.33% | -28.8% | |
| OREXIGEN THERAPEUTICS INCnote 2.750% | $5,475,000 | +82.5% | 10,000,000 | 0.0% | 0.93% | +54.4% | ||
| NVLS | NIVALIS THERAPEUTICS INC | $5,444,000 | +30.4% | 1,864,474 | 0.0% | 0.93% | +10.4% | |
| GTXI | GTX INC DEL | $5,387,000 | -8.0% | 1,108,433 | 0.0% | 0.92% | -22.1% | |
| OREXQ | OREXIGEN THERAPEUTICS INC | $2,528,000 | +97.7% | 734,976 | 0.0% | 0.43% | +67.3% | |
| PTIE | PAIN THERAPEUTICS INC | $2,035,000 | +56.7% | 2,278,552 | 0.0% | 0.35% | +32.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.